Rovi Pharmaceuticals Laboratories

This early-stage study tested a new, long-acting injection of the medication risperidone for schizophrenia. The goal was to see if a single shot given every three months is safe and how the body processes it. The study involved 58 adults with stable schizophrenia who were already…

This study observed how well a long-acting injectable medication called Risperidone ISM worked for adults hospitalized due to a schizophrenia relapse. Researchers followed 275 patients in psychiatric hospitals across Europe to see if the injection helped control symptoms, shorten…